April 2024 Stock Losers on News, Micro Caps Included

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of 2024-04-30, 21 of 22 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of April 2024

100

Ranked drops

-82.71%

Largest, MRNS

92.9%

Below baseline, day +5

8.8%

Median deeper below baseline, day +5

Filter and sort

100 ranked drops in April 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rank	Symbol	close to close	Session	Catalyst	Announcement	from the pre-news close
1	MRNS	-82.71%	2024-04-15 against the close of 2024-04-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Marinus Pharmaceuticals Provides Update on the Phase 3 RAISE Trial and Reports Preliminary First Quarter 2024 Financial Results 04/15/2024 07:00 ET premarket	Day +1 -84.04% 2024-04-16 Day +5 -80.39% 2024-04-22 Best recovery within 5 -80.39% 2024-04-22 2.8% of the drop was recovered five sessions later. Month end -81.25% on 2024-04-30
Close before and after $7.52 to $1.30 as traded Session open, high, low $1.85, $1.95, $1.25 Opening gap -75.40% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 35,571,117 shares, $46,242,452 Relative volume 75.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
2	ACOR	-81.44%	2024-04-02 against the close of 2024-04-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement 04/01/2024 18:35 ET after hours	Day +1 -85.23% 2024-04-03 Day +5 -92.43% 2024-04-09 Best recovery within 5 -85.23% 2024-04-03 Five sessions later the drop was 13.5% bigger, at -92.43%. Month end -94.80% on 2024-04-30
Close before and after $13.47 to $2.50 as traded Session open, high, low $2.21, $4.13, $1.65 Opening gap -83.59% Close inside the session range 0.34 of the range, where 1.00 is the high Session volume 3,737,069 shares, $9,342,673 Relative volume 966.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
3	CASA	-78.64%	2024-04-03 against the close of 2024-04-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Casa Systems Initiates Court-Supervised Chapter 11 Sale Process for Businesses 04/03/2024 07:09 ET premarket	Day +1 -86.41% 2024-04-04 Day +5 -98.06% 2024-04-10 Best recovery within 5 -86.41% 2024-04-04 Five sessions later the drop was 24.7% bigger, at -98.06%. Month end -97.75% on 2024-04-30
Close before and after $0.2575 to $0.0550 as traded Session open, high, low $0.0486, $0.0650, $0.0455 Opening gap -81.13% Close inside the session range 0.49 of the range, where 1.00 is the high Session volume 65,404,429 shares, $3,597,244 Relative volume 314.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
4	EIGR	-72.23%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection 04/01/2024 11:12 ET intraday	Day +1 -74.03% 2024-04-02 Day +5 -57.84% 2024-04-08 Best recovery within 5 -54.05% 2024-04-05 19.9% of the drop was recovered five sessions later. Month end -57.04% on 2024-04-30
Close before and after $5.01 to $1.39 as traded Session open, high, low $5.20, $5.24, $1.10 Opening gap +3.90% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 975,732 shares, $1,356,267 Relative volume 75.2x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
5	BNED	-64.29%	2024-04-16 against the close of 2024-04-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Barnes & Noble Education Adopts Short-Term Stockholder Rights Plan 04/16/2024 09:22 ET premarket Barnes & Noble Education Announces Milestone Transactions to Significantly Strengthen Balance Sheet and Advance Industry Leading Services for Institutions and Students 04/16/2024	Day +1 -65.33% 2024-04-17 Day +5 -70.51% 2024-04-23 Best recovery within 5 -65.33% 2024-04-17 Five sessions later the drop was 9.7% bigger, at -70.51%. Month end -70.94% on 2024-04-30
Close before and after $70.00 to $25.00 split-adjusted Session open, high, low $23.00, $33.90, $18.00 Opening gap -67.14% Close inside the session range 0.44 of the range, where 1.00 is the high Session volume 231,340 shares, $5,783,500 Relative volume 48.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
6	CLVR under $25M today	-60.58%	2024-04-29 against the close of 2024-04-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Clever Leaves Announces Voluntary Delisting and SEC Deregistration 04/26/2024 16:10 ET after hours	Day +1 -61.92% 2024-04-30 Day +5 -56.69% 2024-05-06 Best recovery within 5 -56.69% 2024-05-06 6.4% of the drop was recovered five sessions later. Month end -61.92% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $4.11 to $1.62 split-adjusted Session open, high, low $1.70, $1.91, $1.52 Opening gap -58.64% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 769,704 shares, $1,246,920 Relative volume 82.0x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
7	ANVS	-59.58%	2024-04-29 against the close of 2024-04-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease 04/29/2024 10:10 ET intraday	Day +1 -69.07% 2024-04-30 Day +5 -70.07% 2024-05-06 Best recovery within 5 -66.07% 2024-05-01 Five sessions later the drop was 17.6% bigger, at -70.07%. Month end -69.07% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $18.01 to $7.28 split-adjusted Session open, high, low $18.00, $20.00, $5.23 Opening gap -0.06% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 9,595,452 shares, $69,854,891 Relative volume 49.7x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
8	NA	-54.23%	2024-04-11 against the close of 2024-04-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Nano Labs Announces Pricing of $5.0 Million Registered Direct Offering 04/11/2024 11:30 ET intraday	Day +1 -60.98% 2024-04-12 Day +5 -72.77% 2024-04-18 Best recovery within 5 -60.98% 2024-04-12 Five sessions later the drop was 34.2% bigger, at -72.77%. Month end -68.52% on 2024-04-30
Close before and after $19.30 to $8.83 split-adjusted Session open, high, low $18.50, $19.60, $8.50 Opening gap -4.15% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 502,239 shares, $4,436,277 Relative volume 276.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
9	ENLV	-54.02%	2024-04-11 against the close of 2024-04-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis 04/11/2024 08:05 ET premarket Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis 04/11/2024	Day +1 -60.30% 2024-04-12 Day +5 -64.82% 2024-04-18 Best recovery within 5 -60.30% 2024-04-12 Five sessions later the drop was 20.0% bigger, at -64.82%. Month end -58.04% on 2024-04-30
Close before and after $59.70 to $27.45 split-adjusted Session open, high, low $33.15, $33.60, $24.75 Opening gap -44.47% Close inside the session range 0.31 of the range, where 1.00 is the high Session volume 188,062 shares, $5,162,302 Relative volume 22.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
10	ABEO	-53.67%	2024-04-23 against the close of 2024-04-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Abeona Therapeutics Provides Regulatory Update on Pz-cel 04/22/2024 16:05 ET after hours	Day +1 -56.93% 2024-04-24 Day +5 -43.75% 2024-04-30 Best recovery within 5 -43.75% 2024-04-30 18.5% of the drop was recovered five sessions later. Month end -43.75% on 2024-04-30
Close before and after $7.36 to $3.41 split-adjusted Session open, high, low $3.81, $4.25, $3.34 Opening gap -48.23% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 5,512,776 shares, $18,798,566 Relative volume 27.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
11	VIEW	-53.64%	2024-04-03 against the close of 2024-04-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company 04/02/2024 16:07 ET after hours	Day +1 -70.00% 2024-04-04 Day +5 -83.23% 2024-04-10 Best recovery within 5 -70.00% 2024-04-04 Five sessions later the drop was 55.2% bigger, at -83.23%. Month end -92.25% on 2024-04-30
Close before and after $1.10 to $0.5100 as traded Session open, high, low $0.3887, $0.6660, $0.3777 Opening gap -64.66% Close inside the session range 0.46 of the range, where 1.00 is the high Session volume 2,360,439 shares, $1,203,824 Relative volume 52.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
12	ASTI	-51.22%	2024-04-10 against the close of 2024-04-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Ascent Solar Technologies, Inc. Announces Pricing of $6,000,000 Public Offering of Shares of Common Stock 04/10/2024 08:48 ET premarket	Day +1 -49.84% 2024-04-11 Day +5 -61.29% 2024-04-17 Best recovery within 5 -49.84% 2024-04-11 Five sessions later the drop was 19.7% bigger, at -61.29%. Month end -64.16% on 2024-04-30
Close before and after $27.51 to $13.42 split-adjusted Session open, high, low $13.15, $14.00, $13.00 Opening gap -52.20% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 100,716 shares, $1,351,609 Relative volume 33.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
13	ICLK	-50.99%	2024-04-26 against the close of 2024-04-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition (terminated)	iClick Interactive Asia Group Limited Announces Termination of Merger Agreement 04/26/2024 08:00 ET premarket	Day +1 -53.36% 2024-04-29 Day +5 -50.99% 2024-05-03 Best recovery within 5 -49.80% 2024-05-01 0.0% of the drop was recovered five sessions later. Month end -52.57% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $2.53 to $1.24 as traded Session open, high, low $1.61, $1.61, $1.06 Opening gap -36.36% Close inside the session range 0.33 of the range, where 1.00 is the high Session volume 719,949 shares, $892,737 Relative volume 91.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
14	PACB	-50.62%	2024-04-16 against the close of 2024-04-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance 04/16/2024 08:05 ET premarket	Day +1 -50.62% 2024-04-17 Day +5 -48.15% 2024-04-23 Best recovery within 5 -44.97% 2024-04-22 4.9% of the drop was recovered five sessions later. Month end -41.80% on 2024-04-30
Close before and after $2.84 to $1.40 split-adjusted Session open, high, low $1.95, $2.01, $1.36 Opening gap -31.22% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 65,402,057 shares, $91,562,880 Relative volume 10.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
15	STIX	-48.83%	2024-04-05 against the close of 2024-04-04 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Semantix Announces Voluntary Delisting from the Nasdaq Global Market 04/04/2024 17:01 ET after hours	Day +1 -56.83% 2024-04-08 Day +5 -64.71% 2024-04-12 Best recovery within 5 -52.95% 2024-04-09 Five sessions later the drop was 32.5% bigger, at -64.71%. Month-end is not shown: no closing price is available for 2024-04-30.
Close before and after $0.8501 to $0.4350 as traded Session open, high, low $0.5000, $0.7500, $0.4307 Opening gap -41.18% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 1,395,276 shares, $606,945 Relative volume 114.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
16	GCTS Also on the opposite board this month on both boards	-45.28%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change	GCT Semiconductor Appoints Nelson C. Chan to Board of Directors 04/01/2024 08:00 ET premarket	Day +1 -53.12% 2024-04-02 Day +5 -78.83% 2024-04-08 Best recovery within 5 -53.12% 2024-04-02 Five sessions later the drop was 74.1% bigger, at -78.83%. Month end -85.72% on 2024-04-30
Close before and after $33.06 to $18.09 split-adjusted Session open, high, low $29.00, $30.52, $17.00 Opening gap -12.28% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 313,826 shares, $5,677,112 Relative volume 123.1x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
17	IRON	-45.05%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) 04/01/2024 08:00 ET premarket	Day +1 -48.55% 2024-04-02 Day +5 -48.96% 2024-04-08 Best recovery within 5 -48.55% 2024-04-02 Five sessions later the drop was 8.7% bigger, at -48.96%. Month end -55.28% on 2024-04-30
Close before and after $62.26 to $34.21 split-adjusted Session open, high, low $26.50, $35.40, $25.60 Opening gap -57.44% Close inside the session range 0.88 of the range, where 1.00 is the high Session volume 6,219,216 shares, $212,759,379 Relative volume 18.7x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
18	AILE	-44.44%	2024-04-17 against the close of 2024-04-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Reverse Merger / Shell	iLearningEngines, Inc. Becomes Publicly Traded Company After Completing Business Combination With Arrowroot Acquisition Corp., Will Commence Trading on Nasdaq Under Ticker Symbol “AILE” 04/16/2024 16:05 ET after hours iLearningEngines, Inc. Announces Additional Funding in Connection With Its Business Combination; Brings Gross Proceeds to Approximately $92.8 Million 04/17/2024	Day +1 -60.50% 2024-04-18 Day +5 -61.11% 2024-04-24 Best recovery within 5 -59.50% 2024-04-23 Five sessions later the drop was 37.5% bigger, at -61.11%. Month end -63.86% on 2024-04-30
Close before and after $18.00 to $10.00 as traded Session open, high, low $10.28, $11.59, $8.29 Opening gap -42.89% Close inside the session range 0.52 of the range, where 1.00 is the high Session volume 132,897 shares, $1,328,970 Relative volume 17.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
19	SINT under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-43.77%	2024-04-03 against the close of 2024-04-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock 04/03/2024 09:00 ET premarket	Day +1 -38.63% 2024-04-04 Day +5 -39.36% 2024-04-10 Best recovery within 5 -37.65% 2024-04-09 10.1% of the drop was recovered five sessions later. Month end +11.00% on 2024-04-30
Close before and after $8.18 to $4.60 split-adjusted Session open, high, low $4.44, $4.90, $4.34 Opening gap -45.72% Close inside the session range 0.46 of the range, where 1.00 is the high Session volume 434,118 shares, $1,996,943 Relative volume 78.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
20	VAXX under $25M today	-43.37%	2024-04-22 against the close of 2024-04-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Vaxxinity Issues Shareholder Letter 04/19/2024 18:53 ET after hours Vaxxinity Announces Intention to Voluntarily Delist and Deregister its Class A Common Stock 04/19/2024	Day +1 -57.99% 2024-04-23 Day +5 -67.76% 2024-04-29 Best recovery within 5 -57.99% 2024-04-23 Five sessions later the drop was 56.2% bigger, at -67.76%. Month end -74.23% on 2024-04-30
Close before and after $0.4761 to $0.2696 split-adjusted Session open, high, low $0.2067, $0.2875, $0.1900 Opening gap -56.58% Close inside the session range 0.82 of the range, where 1.00 is the high Session volume 5,859,924 shares, $1,579,836 Relative volume 19.6x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
21	PERI	-40.79%	2024-04-08 against the close of 2024-04-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Perion Network Announces Preliminary Q1 2024 Financial Results 04/08/2024 06:00 ET premarket	Day +1 -37.57% 2024-04-09 Day +5 -44.39% 2024-04-15 Best recovery within 5 -37.57% 2024-04-09 Five sessions later the drop was 8.8% bigger, at -44.39%. Month end -40.36% on 2024-04-30
Close before and after $21.11 to $12.50 split-adjusted Session open, high, low $13.09, $13.98, $12.10 Opening gap -37.99% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 13,142,569 shares, $164,282,113 Relative volume 33.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
22	LGVN under $25M today Also on the opposite board this month on both boards	-40.79%	2024-04-17 against the close of 2024-04-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds 04/17/2024 08:00 ET premarket	Day +1 -43.06% 2024-04-18 Day +5 -51.27% 2024-04-24 Best recovery within 5 -43.06% 2024-04-18 Five sessions later the drop was 25.7% bigger, at -51.27%. Month end -51.56% on 2024-04-30
Close before and after $3.53 to $2.09 split-adjusted Session open, high, low $2.53, $2.68, $1.93 Opening gap -28.33% Close inside the session range 0.21 of the range, where 1.00 is the high Session volume 3,380,408 shares, $7,065,053 Relative volume 29.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
23	SKIL More than one ranked move this month 2+ ranked moves	-40.76%	2024-04-16 against the close of 2024-04-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Skillsoft Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024 04/15/2024 16:05 ET after hours Skillsoft Announces Leadership Transition 04/15/2024	Day +1 -37.17% 2024-04-17 Day +5 -37.93% 2024-04-23 Best recovery within 5 -37.17% 2024-04-17 6.9% of the drop was recovered five sessions later. Month end -21.85% on 2024-04-30
Close before and after $9.20 to $5.45 split-adjusted Session open, high, low $7.15, $7.58, $5.40 Opening gap -22.28% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 261,757 shares, $1,426,576 Relative volume 7.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
24	VLD under $25M today	-38.89%	2024-04-10 against the close of 2024-04-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Velo3D Announces Proposed Public Offering 04/09/2024 17:00 ET after hours Velo3D Announces Pricing of $12 Million Public Offering 04/10/2024	Day +1 -28.61% 2024-04-11 Day +5 -41.07% 2024-04-17 Best recovery within 5 -28.61% 2024-04-11 Five sessions later the drop was 5.6% bigger, at -41.07%. Month end -43.05% on 2024-04-30
Close before and after $16.26 to $9.94 as traded Session open, high, low $10.40, $10.50, $9.27 Opening gap -36.07% Close inside the session range 0.54 of the range, where 1.00 is the high Session volume 698,833 shares, $6,943,954 Relative volume 2.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
25	RVYL under $25M today	-36.44%	2024-04-16 against the close of 2024-04-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	RYVYL Inc. Announces Launch of Proposed Underwritten Public Offering 04/15/2024 16:27 ET after hours RYVYL Inc. Announces Cancellation of Proposed Underwritten Public Offering 04/16/2024	Day +1 -32.07% 2024-04-17 Day +5 -20.12% 2024-04-23 Best recovery within 5 -20.12% 2024-04-23 44.8% of the drop was recovered five sessions later. Month end -35.95% on 2024-04-30
Close before and after $72.14 to $45.85 as traded Session open, high, low $56.00, $56.00, $44.45 Opening gap -22.37% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 26,323 shares, $1,206,910 Relative volume 47.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
26	WISA under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-36.32%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	WiSA Strikes Game-Changing Fifth WiSA E Licensing Deal with Global Consumer Electronics Leader 04/18/2024 08:45 ET premarket	Day +1 -34.49% 2024-04-19 Day +5 -33.30% 2024-04-25 Best recovery within 5 -33.30% 2024-04-25 8.3% of the drop was recovered five sessions later. Month end -40.11% on 2024-04-30
Close before and after $9.25 to $5.89 as traded Session open, high, low $6.00, $7.54, $5.75 Opening gap -35.14% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 16,093,236 shares, $94,789,160 Relative volume 47.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
27	AEON under $25M today	-35.95%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results 03/29/2024 15:45 ET intraday AEON Biopharma Announces Redemption of Public Warrants 03/29/2024 CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants 03/30/2024	Day +1 -33.45% 2024-04-02 Day +5 -26.29% 2024-04-08 Best recovery within 5 -26.29% 2024-04-08 26.9% of the drop was recovered five sessions later. Month end -66.81% on 2024-04-30
Close before and after $835.20 to $534.96 split-adjusted Session open, high, low $536.40, $549.36, $455.62 Opening gap -35.78% Close inside the session range 0.85 of the range, where 1.00 is the high Session volume 2,980 shares, $1,594,181 Relative volume 3.0x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
28	SRZN	-35.71%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules 04/01/2024 08:30 ET premarket Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043 04/01/2024	Day +1 -39.72% 2024-04-02 Day +5 -28.52% 2024-04-08 Best recovery within 5 -27.88% 2024-04-04 20.1% of the drop was recovered five sessions later. Month end -31.51% on 2024-04-30
Close before and after $15.71 to $10.10 split-adjusted Session open, high, low $14.30, $14.96, $9.75 Opening gap -8.98% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 222,310 shares, $2,245,331 Relative volume 42.0x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
29	VERV	-34.95%	2024-04-02 against the close of 2024-04-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Verve Therapeutics Announces Updates on its PCSK9 Program 04/02/2024 07:00 ET premarket	Day +1 -31.90% 2024-04-03 Day +5 -31.59% 2024-04-09 Best recovery within 5 -31.59% 2024-04-09 9.6% of the drop was recovered five sessions later. Month end -53.01% on 2024-04-30
Close before and after $12.79 to $8.32 as traded Session open, high, low $8.67, $9.28, $7.36 Opening gap -32.21% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 10,026,941 shares, $83,424,149 Relative volume 11.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
30	MVST	-34.08%	2024-04-02 against the close of 2024-04-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Microvast Reports 2023 Financial Results 04/01/2024 17:00 ET after hours	Day +1 -32.22% 2024-04-03 Day +5 -43.46% 2024-04-09 Best recovery within 5 -32.22% 2024-04-03 Five sessions later the drop was 27.5% bigger, at -43.46%. Month end -56.21% on 2024-04-30
Close before and after $0.8950 to $0.5900 split-adjusted Session open, high, low $0.6429, $0.6500, $0.5300 Opening gap -28.17% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 14,103,897 shares, $8,321,299 Relative volume 3.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
31	MTBL More than one ranked move this month 2+ ranked moves	-33.33%	2024-04-04 against the close of 2024-04-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Moatable Announces Delisting Proceedings of the ADS by NYSE 04/04/2024 06:00 ET premarket	Day +1 -53.76% 2024-04-05 Day +5 +13.33% 2024-04-11 Best recovery within 5 +13.33% 2024-04-09 It recovered the whole drop and closed 13.33% above the pre-news price. Month end +52.22% on 2024-04-30
Close before and after $0.4500 to $0.3000 as traded Session open, high, low $0.2100, $0.3900, $0.2100 Opening gap -53.33% Close inside the session range 0.50 of the range, where 1.00 is the high Session volume 256,329 shares, $76,899 Relative volume 14.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
32	SPCB Also on the opposite board this month on both boards	-33.31%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	SuperCom Announces Pricing of $2.9 Million Registered Direct Offering 04/18/2024 08:30 ET premarket SuperCom to Report Fourth Quarter and Full Year 2023 Financial Results on April 22, 2024 04/18/2024	Day +1 -38.87% 2024-04-19 Day +5 -29.98% 2024-04-25 Best recovery within 5 -19.51% 2024-04-22 10.0% of the drop was recovered five sessions later. Month end -38.46% on 2024-04-30
Close before and after $7.20 to $4.80 split-adjusted Session open, high, low $6.18, $6.30, $4.80 Opening gap -14.12% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 428,390 shares, $2,056,272 Relative volume 4.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
33	ATNI	-32.80%	2024-04-25 against the close of 2024-04-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	ATN Reports First Quarter 2024 Results; Revises Full Year 2024 Outlook 04/24/2024 16:30 ET after hours	Day +1 -32.03% 2024-04-26 Day +5 -26.78% 2024-05-02 Best recovery within 5 -26.78% 2024-05-02 18.4% of the drop was recovered five sessions later. Month end -33.57% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $28.72 to $19.30 split-adjusted Session open, high, low $24.72, $24.72, $18.20 Opening gap -13.93% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 440,202 shares, $8,495,899 Relative volume 7.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
34	BKKT	-32.63%	2024-04-30 against the close of 2024-04-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings (date set)	Bakkt Schedules Conference Call to Discuss First Quarter 2024 Results 04/30/2024 08:15 ET premarket	Day +1 -36.65% 2024-05-01 Day +5 -26.81% 2024-05-07 Best recovery within 5 -26.81% 2024-05-07 17.8% of the drop was recovered five sessions later. Month end -32.63% on 2024-04-30 same session This month ended before the fifth session after the move.
Close before and after $9.96 to $6.71 split-adjusted Session open, high, low $9.60, $9.78, $6.51 Opening gap -3.61% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 1,337,890 shares, $8,977,242 Relative volume 9.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
35	VIRX under $25M today	-32.17%	2024-04-15 against the close of 2024-04-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma 04/15/2024 08:00 ET premarket	Day +1 -37.84% 2024-04-16 Day +5 -23.48% 2024-04-22 Best recovery within 5 -18.58% 2024-04-17 27.0% of the drop was recovered five sessions later. Month end -28.73% on 2024-04-30
Close before and after $1.15 to $0.7800 as traded Session open, high, low $1.03, $1.04, $0.7600 Opening gap -10.43% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 606,565 shares, $473,121 Relative volume 7.9x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
36	FGEN	-31.94%	2024-04-03 against the close of 2024-04-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer 04/02/2024 17:46 ET after hours	Day +1 -26.85% 2024-04-04 Day +5 -33.80% 2024-04-10 Best recovery within 5 -24.54% 2024-04-08 Five sessions later the drop was 5.8% bigger, at -33.80%. Month end -48.15% on 2024-04-30
Close before and after $54.00 to $36.75 as traded Session open, high, low $53.50, $53.75, $29.50 Opening gap -0.93% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 413,658 shares, $15,201,932 Relative volume 6.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
37	MTBL More than one ranked move this month 2+ ranked moves	-30.60%	2024-04-03 against the close of 2024-04-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Moatable Announces 2024 Annual Meeting of Shareholders 04/02/2024 16:00 ET after hours	Day +1 -53.73% 2024-04-04 Day +5 -22.89% 2024-04-10 Best recovery within 5 -21.34% 2024-04-09 25.2% of the drop was recovered five sessions later. Month end +5.64% on 2024-04-30
Close before and after $0.6484 to $0.4500 as traded Session open, high, low $0.6350, $0.6350, $0.4400 Opening gap -2.07% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 180,315 shares, $81,142 Relative volume 10.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
38	NDRA under $25M today	-30.50%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update 03/28/2024 16:05 ET after hours	Day +1 -36.93% 2024-04-02 Day +5 -38.97% 2024-04-08 Best recovery within 5 -35.34% 2024-04-05 Five sessions later the drop was 27.8% bigger, at -38.97%. Month end -51.22% on 2024-04-30
Close before and after $1,015.00 to $705.43 split-adjusted Session open, high, low $785.75, $875.00, $686.88 Opening gap -22.59% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 690 shares, $486,743 Relative volume 7.1x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
39	VVOS under $25M today	-30.23%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update 03/28/2024 16:05 ET after hours	Day +1 -29.92% 2024-04-02 Day +5 -37.27% 2024-04-08 Best recovery within 5 -29.92% 2024-04-02 Five sessions later the drop was 23.3% bigger, at -37.27%. Month end -47.62% on 2024-04-30
Close before and after $4.83 to $3.37 split-adjusted Session open, high, low $3.75, $3.99, $3.33 Opening gap -22.36% Close inside the session range 0.06 of the range, where 1.00 is the high Session volume 399,573 shares, $1,346,561 Relative volume 6.1x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
40	VIAO under $25M today Also on the opposite board this month on both boards	-30.00%	2024-04-10 against the close of 2024-04-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	VIA optronics and Antolin unveil Sunrise, a New Horizon of Integration in Vehicle Cockpits 04/10/2024 06:30 ET premarket	Day +1 -50.00% 2024-04-11 Day +5 -70.89% 2024-04-17 Best recovery within 5 -50.00% 2024-04-11 Five sessions later the drop was 136.3% bigger, at -70.89%. Month end -78.89% on 2024-04-30
Close before and after $0.9000 to $0.6300 as traded Session open, high, low $0.5799, $0.6400, $0.3615 Opening gap -35.57% Close inside the session range 0.96 of the range, where 1.00 is the high Session volume 1,039,379 shares, $654,809 Relative volume 262.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
41	LAC	-29.71%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Lithium Americas Announces Proposed Public Offering of Common Shares 04/17/2024 17:07 ET after hours Lithium Americas Prices US$275 Million Underwritten Public Offering 04/18/2024	Day +1 -28.66% 2024-04-19 Day +5 -33.33% 2024-04-25 Best recovery within 5 -28.36% 2024-04-22 Five sessions later the drop was 12.2% bigger, at -33.33%. Month end -33.48% on 2024-04-30
Close before and after $6.63 to $4.66 split-adjusted Session open, high, low $4.84, $4.90, $4.64 Opening gap -27.00% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 32,100,176 shares, $149,586,820 Relative volume 9.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
42	WRNT under $25M today	-29.41%	2024-04-22 against the close of 2024-04-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Warrantee Inc. Announces Receipt of Nasdaq Delisting Determination and Plan to Appeal 04/19/2024 16:05 ET after hours	Day +1 -33.60% 2024-04-23 Day +5 -36.47% 2024-04-29 Best recovery within 5 -31.20% 2024-04-26 Five sessions later the drop was 24.0% bigger, at -36.47%. Month end -29.44% on 2024-04-30
Close before and after $0.4250 to $0.3000 as traded Session open, high, low $0.4110, $0.4394, $0.2504 Opening gap -3.29% Close inside the session range 0.26 of the range, where 1.00 is the high Session volume 498,316 shares, $149,495 Relative volume 26.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
43	SIEN	-29.12%	2024-04-03 against the close of 2024-04-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction 04/02/2024 18:30 ET after hours	Day +1 -17.58% 2024-04-04 Day +5 -44.45% 2024-04-10 Best recovery within 5 -17.58% 2024-04-04 Five sessions later the drop was 52.6% bigger, at -44.45%. Month-end is not shown: no closing price is available for 2024-04-30.
Close before and after $0.1820 to $0.1290 as traded Session open, high, low $0.1200, $0.1700, $0.1200 Opening gap -34.07% Close inside the session range 0.18 of the range, where 1.00 is the high Session volume 299,526 shares, $38,639 Relative volume 5.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
44	WISA under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-28.71%	2024-04-22 against the close of 2024-04-19 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	WiSA Technologies to Present at the Planet MicroCap Showcase in Las Vegas 04/22/2024 07:00 ET premarket	Day +1 -11.06% 2024-04-23 Day +5 -16.01% 2024-04-29 Best recovery within 5 +1.82% 2024-04-25 44.2% of the drop was recovered five sessions later. Month end -8.58% on 2024-04-30
Close before and after $6.06 to $4.32 as traded Session open, high, low $6.01, $6.02, $4.32 Opening gap -0.83% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 4,171,739 shares, $18,021,912 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
45	RCEL	-28.32%	2024-04-11 against the close of 2024-04-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AVITA Medical Updates Expected First Quarter 2024 Revenue 04/10/2024 17:11 ET after hours	Day +1 -31.58% 2024-04-12 Day +5 -38.57% 2024-04-18 Best recovery within 5 -31.58% 2024-04-12 Five sessions later the drop was 36.2% bigger, at -38.57%. Month end -41.83% on 2024-04-30
Close before and after $14.44 to $10.35 split-adjusted Session open, high, low $12.28, $12.38, $9.86 Opening gap -14.96% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 2,058,258 shares, $21,302,970 Relative volume 15.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
46	SHCR	-28.29%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Sharecare announces fourth quarter and full year 2023 financial results and operational highlights 03/28/2024 16:05 ET after hours	Day +1 -16.93% 2024-04-02 Day +5 +4.09% 2024-04-08 Best recovery within 5 +4.09% 2024-04-08 It recovered the whole drop and closed 4.09% above the pre-news price. Month end -6.72% on 2024-04-30
Close before and after $0.7675 to $0.5504 as traded Session open, high, low $0.7400, $0.7401, $0.4811 Opening gap -3.58% Close inside the session range 0.27 of the range, where 1.00 is the high Session volume 11,131,813 shares, $6,126,950 Relative volume 9.6x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
47	CHGG	-27.89%	2024-04-30 against the close of 2024-04-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Chegg Reports 2024 First Quarter Earnings 04/29/2024 16:05 ET after hours Chegg Announces Appointment of Nathan Schultz as Chief Executive Officer 04/29/2024	Day +1 -24.97% 2024-05-01 Day +5 -29.43% 2024-05-07 Best recovery within 5 -24.97% 2024-05-01 Five sessions later the drop was 5.5% bigger, at -29.43%. Month end -27.89% on 2024-04-30 same session This month ended before the fifth session after the move.
Close before and after $7.17 to $5.17 split-adjusted Session open, high, low $6.22, $6.23, $5.11 Opening gap -13.25% Close inside the session range 0.05 of the range, where 1.00 is the high Session volume 18,726,047 shares, $96,813,663 Relative volume 9.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
48	INLX under $25M today	-27.86%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Intellinetics Grows 2023 Full-Year Revenues 21% 03/28/2024 16:06 ET after hours	Day +1 -23.67% 2024-04-02 Day +5 -17.33% 2024-04-08 Best recovery within 5 -17.33% 2024-04-08 37.8% of the drop was recovered five sessions later. Month end -20.72% on 2024-04-30
Close before and after $8.83 to $6.37 split-adjusted Session open, high, low $8.82, $8.82, $5.86 Opening gap -0.11% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 73,273 shares, $466,749 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
49	NRXP More than one ranked move this month 2+ ranked moves	-27.75%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	NRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock 04/17/2024 16:45 ET after hours NRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock 04/18/2024 NRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement 04/18/2024	Day +1 -27.27% 2024-04-19 Day +5 -24.88% 2024-04-25 Best recovery within 5 -24.88% 2024-04-25 10.3% of the drop was recovered five sessions later. Month end -38.28% on 2024-04-30
Close before and after $4.18 to $3.02 split-adjusted Session open, high, low $3.03, $3.26, $3.00 Opening gap -27.51% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 768,977 shares, $2,322,311 Relative volume 4.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
50	GOEV under $25M today release reads positive	-27.65%	2024-04-02 against the close of 2024-04-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings catalyst from a later release the same session Release reads positive, stock fell 27.65%	Canoo Enters a $30 Billion Market with Multiple Commercial Vehicle Sales in Saudi Arabia 04/02/2024 06:00 ET premarket Canoo Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results 04/01/2024	Day +1 -36.18% 2024-04-03 Day +5 -37.47% 2024-04-09 Best recovery within 5 -36.18% 2024-04-03 Five sessions later the drop was 35.5% bigger, at -37.47%. Month end -25.58% on 2024-04-30
Close before and after $77.40 to $56.00 as traded Session open, high, low $49.60, $58.40, $47.00 Opening gap -35.91% Close inside the session range 0.79 of the range, where 1.00 is the high Session volume 659,724 shares, $36,944,544 Relative volume 1.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
51	GAME Also on the opposite board this month on both boards	-27.41%	2024-04-17 against the close of 2024-04-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	GameSquare Holdings Reports 2023 Results 04/16/2024 16:05 ET after hours	Day +1 -23.35% 2024-04-18 Day +5 -24.37% 2024-04-24 Best recovery within 5 -23.35% 2024-04-18 11.1% of the drop was recovered five sessions later. Month end -27.92% on 2024-04-30
Close before and after $15.76 to $11.44 split-adjusted Session open, high, low $14.72, $15.12, $11.04 Opening gap -6.60% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 40,538 shares, $463,755 Relative volume 3.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
52	KULR Also on the opposite board this month on both boards	-27.32%	2024-04-15 against the close of 2024-04-12 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Leadership Change catalyst from a later release the same session	KULR Technology Group Reports Record Annual Revenue for 2023 04/12/2024 16:15 ET after hours KULR Technology Group Announces Appointment of Donna H. Grier to its Board of Directors 04/15/2024	Day +1 -36.94% 2024-04-16 Day +5 -44.27% 2024-04-22 Best recovery within 5 -36.94% 2024-04-16 Five sessions later the drop was 62.0% bigger, at -44.27%. Month end -39.65% on 2024-04-30
Close before and after $6.41 to $4.66 split-adjusted Session open, high, low $5.41, $5.60, $4.48 Opening gap -15.61% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 1,431,931 shares, $6,669,362 Relative volume 0.8x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
53	NRXP More than one ranked move this month 2+ ranked moves	-27.32%	2024-04-30 against the close of 2024-04-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	NRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising Findings in Phase 2b/3 Clinical Trial of NRX-101 vs. Lurasidone for Treatment of Suicidal Bipolar Depression 04/30/2024 08:30 ET premarket	Day +1 -38.59% 2024-05-01 Day +5 -20.85% 2024-05-07 Best recovery within 5 -13.80% 2024-05-06 23.7% of the drop was recovered five sessions later. Month end -27.32% on 2024-04-30 same session This month ended before the fifth session after the move.
Close before and after $3.55 to $2.58 split-adjusted Session open, high, low $2.28, $2.95, $2.27 Opening gap -35.77% Close inside the session range 0.46 of the range, where 1.00 is the high Session volume 937,633 shares, $2,419,093 Relative volume 5.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
54	JOAN	-27.27%	2024-04-26 against the close of 2024-04-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	JOANN Receives Court Approval for Prepackaged Financial Recapitalization Plan 04/25/2024 16:15 ET after hours	Day +1 -24.55% 2024-04-29 Day +5 no data Best recovery within 5 -24.55% 2024-04-29 Month end -31.00% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $0.1100 to $0.0800 as traded Session open, high, low $0.1100, $0.1100, $0.0751 Opening gap 0.00% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 1,175,684 shares, $94,055 Relative volume 2.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
55	NKLA	-26.73%	2024-04-11 against the close of 2024-04-10 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	M&M Residual and Trevor R. Milton Announce Concerns Related to Potential Fraud and Misconduct at Nikola Overseen by Steve Girsky, Britton Worthen and the Board of Directors 04/11/2024 11:30 ET intraday	Day +1 -28.44% 2024-04-12 Day +5 -32.56% 2024-04-18 Best recovery within 5 -28.44% 2024-04-12 Five sessions later the drop was 21.8% bigger, at -32.56%. Month end -36.58% on 2024-04-30
Close before and after $29.36 to $21.51 as traded Session open, high, low $27.75, $28.18, $21.36 Opening gap -5.48% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 9,805,285 shares, $210,911,680 Relative volume 3.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
56	TPET under $25M today Also on the opposite board this month on both boards	-26.15%	2024-04-09 against the close of 2024-04-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Company Retires $2.6 Million Convertible Note 04/09/2024 07:00 ET premarket	Day +1 +9.43% 2024-04-10 Day +5 +191.28% 2024-04-16 Best recovery within 5 +276.12% 2024-04-15 It recovered the whole drop and closed 191.28% above the pre-news price. Month end +93.49% on 2024-04-30
Close before and after $3.35 to $2.47 split-adjusted Session open, high, low $3.04, $3.08, $2.42 Opening gap -9.37% Close inside the session range 0.08 of the range, where 1.00 is the high Session volume 491,033 shares, $1,214,816 Relative volume 6.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
57	RCAT	-25.35%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Red Cat Announces Agreement with Sentien Robotics UAS Hive for Land, Air and Sea Drone Swarming Operations 04/18/2024 06:33 ET premarket	Day +1 -21.13% 2024-04-19 Day +5 +2.82% 2024-04-25 Best recovery within 5 +7.04% 2024-04-24 It recovered the whole drop and closed 2.82% above the pre-news price. Month end +7.75% on 2024-04-30
Close before and after $1.42 to $1.06 split-adjusted Session open, high, low $1.43, $1.44, $0.9000 Opening gap +0.70% Close inside the session range 0.30 of the range, where 1.00 is the high Session volume 3,772,956 shares, $3,999,333 Relative volume 18.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
58	KOPN	-25.33%	2024-04-23 against the close of 2024-04-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Kopin Corporation versus BlueRadios Inc. Update 04/23/2024 09:00 ET premarket Kopin Exhibiting at SPIE Defense & Commercial Sensing Conference at the National Harbor, MD April 23 through April 25, 2024 04/23/2024	Day +1 -33.49% 2024-04-24 Day +5 -39.07% 2024-04-30 Best recovery within 5 -33.49% 2024-04-24 Five sessions later the drop was 54.2% bigger, at -39.07%. Month end -39.07% on 2024-04-30
Close before and after $1.29 to $0.9633 split-adjusted Session open, high, low $1.29, $1.30, $0.9500 Opening gap 0.00% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 7,776,112 shares, $7,490,729 Relative volume 8.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
59	TOON	-25.00%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	Kartoon Studios Inc. Announces Pricing of up to $7 Million Registered Direct Offering of Common Stock 04/18/2024 09:00 ET premarket	Day +1 -27.03% 2024-04-19 Day +5 -23.65% 2024-04-25 Best recovery within 5 -22.97% 2024-04-23 5.4% of the drop was recovered five sessions later. Month end -27.03% on 2024-04-30
Close before and after $1.48 to $1.11 split-adjusted Session open, high, low $1.19, $1.21, $1.09 Opening gap -19.59% Close inside the session range 0.17 of the range, where 1.00 is the high Session volume 1,561,854 shares, $1,733,658 Relative volume 10.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
60	PALI Also on the opposite board this month on both boards	-24.91%	2024-04-10 against the close of 2024-04-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™ 04/10/2024 08:15 ET premarket	Day +1 -19.19% 2024-04-11 Day +5 +21.77% 2024-04-17 Best recovery within 5 +21.77% 2024-04-17 It recovered the whole drop and closed 21.77% above the pre-news price. Month end +11.25% on 2024-04-30
Close before and after $5.42 to $4.07 split-adjusted Session open, high, low $5.09, $5.22, $4.07 Opening gap -6.09% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 175,967 shares, $716,186 Relative volume 23.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
61	ACHL	-24.76%	2024-04-04 against the close of 2024-04-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning 04/04/2024 06:30 ET premarket Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights 04/04/2024	Day +1 -29.92% 2024-04-05 Day +5 -29.17% 2024-04-11 Best recovery within 5 -29.17% 2024-04-11 Five sessions later the drop was 17.8% bigger, at -29.17%. Month end -37.50% on 2024-04-30
Close before and after $1.20 to $0.9029 as traded Session open, high, low $0.9802, $0.9899, $0.8500 Opening gap -18.32% Close inside the session range 0.38 of the range, where 1.00 is the high Session volume 2,287,105 shares, $2,065,027 Relative volume 8.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
62	SGH	-24.07%	2024-04-10 against the close of 2024-04-09 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	SGH Reports Second Quarter Fiscal 2024 Financial Results 04/09/2024 16:05 ET after hours	Day +1 -25.00% 2024-04-11 Day +5 -28.78% 2024-04-17 Best recovery within 5 -24.61% 2024-04-12 Five sessions later the drop was 19.6% bigger, at -28.78%. Month end -29.51% on 2024-04-30
Close before and after $25.92 to $19.68 as traded Session open, high, low $22.88, $23.56, $19.21 Opening gap -11.73% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 6,536,051 shares, $128,629,484 Relative volume 8.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
63	HRYU under $25M today	-23.58%	2024-04-25 against the close of 2024-04-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Hanryu Holdings, Inc. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq 04/24/2024 19:40 ET after hours	Day +1 -15.94% 2024-04-26 Day +5 +1.30% 2024-05-02 Best recovery within 5 +1.30% 2024-05-02 It recovered the whole drop and closed 1.30% above the pre-news price. Month end -2.86% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $0.5250 to $0.4012 as traded Session open, high, low $0.4990, $0.5022, $0.2100 Opening gap -4.95% Close inside the session range 0.65 of the range, where 1.00 is the high Session volume 1,235,416 shares, $495,649 Relative volume 2.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
64	ASTS	-23.57%	2024-04-02 against the close of 2024-04-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	AST SpaceMobile Provides Business Update and Fourth Quarter and Full Year 2023 Results 04/01/2024 16:30 ET after hours	Day +1 -11.79% 2024-04-03 Day +5 -12.17% 2024-04-09 Best recovery within 5 -11.79% 2024-04-03 48.4% of the drop was recovered five sessions later. Month end -15.97% on 2024-04-30
Close before and after $2.63 to $2.01 split-adjusted Session open, high, low $2.34, $2.36, $1.97 Opening gap -11.03% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 11,977,684 shares, $24,075,145 Relative volume 3.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
65	BLRX under $25M today	-23.20%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	BioLineRx Announces $6 Million Registered Direct Offering 04/01/2024 09:00 ET premarket	Day +1 -25.95% 2024-04-02 Day +5 -32.01% 2024-04-08 Best recovery within 5 -25.95% 2024-04-02 Five sessions later the drop was 38.0% bigger, at -32.01%. Month end -40.23% on 2024-04-30
Close before and after $44.80 to $34.41 split-adjusted Session open, high, low $38.08, $44.00, $34.00 Opening gap -15.00% Close inside the session range 0.04 of the range, where 1.00 is the high Session volume 56,032 shares, $1,927,949 Relative volume 9.4x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
66	SMCI	-23.14%	2024-04-19 against the close of 2024-04-18 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Supermicro to Announce Third Quarter Fiscal 2024 Earnings on April 30, 2024 04/19/2024 09:05 ET premarket	Day +1 -22.77% 2024-04-22 Day +5 -7.65% 2024-04-26 Best recovery within 5 -7.65% 2024-04-26 66.9% of the drop was recovered five sessions later. Month end -7.50% on 2024-04-30
Close before and after $92.85 to $71.37 split-adjusted Session open, high, low $87.10, $89.08, $71.10 Opening gap -6.19% Close inside the session range 0.02 of the range, where 1.00 is the high Session volume 172,385,020 shares, $12,302,256,952 Relative volume 3.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
67	PPSI	-22.90%	2024-04-02 against the close of 2024-04-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Pioneer Achieves 51% Year-Over-Year Increase in Revenue, Reaching $40.8 Million 04/01/2024 16:05 ET after hours	Day +1 -23.74% 2024-04-03 Day +5 -27.95% 2024-04-09 Best recovery within 5 -23.74% 2024-04-03 Five sessions later the drop was 22.1% bigger, at -27.95%. Month end -36.03% on 2024-04-30
Close before and after $5.94 to $4.58 split-adjusted Session open, high, low $4.85, $4.98, $4.33 Opening gap -18.35% Close inside the session range 0.39 of the range, where 1.00 is the high Session volume 1,084,723 shares, $4,968,031 Relative volume 9.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
68	ICU under $25M today	-22.79%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	SeaStar Medical Reports 2023 Financial Results and Provides a Business Update 04/17/2024 16:00 ET after hours	Day +1 -42.09% 2024-04-19 Day +5 -31.00% 2024-04-25 Best recovery within 5 -27.29% 2024-04-24 Five sessions later the drop was 36.0% bigger, at -31.00%. Month end -31.34% on 2024-04-30
Close before and after $174.85 to $135.00 split-adjusted Session open, high, low $157.50, $160.00, $125.05 Opening gap -9.92% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 24,324 shares, $3,283,740 Relative volume 3.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
69	OCUL	-22.69%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy 04/18/2024 07:00 ET premarket	Day +1 -31.13% 2024-04-19 Day +5 -44.59% 2024-04-25 Best recovery within 5 -31.13% 2024-04-19 Five sessions later the drop was 96.5% bigger, at -44.59%. Month end -37.47% on 2024-04-30
Close before and after $7.58 to $5.86 split-adjusted Session open, high, low $7.60, $7.61, $5.85 Opening gap +0.26% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 6,074,050 shares, $35,593,933 Relative volume 4.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
70	PRZO under $25M today	-22.59%	2024-04-16 against the close of 2024-04-15 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	ParaZero Develops Counter Drone Solutions Leveraging Its Unique Technology 04/16/2024 07:31 ET premarket	Day +1 -26.55% 2024-04-17 Day +5 -33.95% 2024-04-23 Best recovery within 5 -26.55% 2024-04-17 Five sessions later the drop was 50.3% bigger, at -33.95%. Month end -32.95% on 2024-04-30
Close before and after $1.11 to $0.8592 split-adjusted Session open, high, low $1.19, $1.21, $0.8127 Opening gap +7.21% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 13,921,269 shares, $11,961,154 Relative volume 72.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
71	BRFH under $25M today	-22.53%	2024-04-26 against the close of 2024-04-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Barfresh Highlights Many New Wins With its Smoothies in the Education Channel 04/26/2024 10:06 ET intraday	Day +1 -13.74% 2024-04-29 Day +5 -2.20% 2024-05-03 Best recovery within 5 +6.04% 2024-05-01 90.2% of the drop was recovered five sessions later. Month end -12.09% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $1.82 to $1.41 split-adjusted Session open, high, low $1.68, $1.69, $1.41 Opening gap -7.69% Close inside the session range 0.00 of the range, where 1.00 is the high Session volume 1,119,584 shares, $1,578,613 Relative volume 398.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
72	MED	-22.47%	2024-04-30 against the close of 2024-04-29 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Medifast Announces First Quarter 2024 Financial Results 04/29/2024 16:05 ET after hours	Day +1 -25.77% 2024-05-01 Day +5 -28.16% 2024-05-07 Best recovery within 5 -24.84% 2024-05-03 Five sessions later the drop was 25.3% bigger, at -28.16%. Month end -22.47% on 2024-04-30 same session This month ended before the fifth session after the move.
Close before and after $35.51 to $27.53 split-adjusted Session open, high, low $26.60, $29.63, $26.02 Opening gap -25.09% Close inside the session range 0.42 of the range, where 1.00 is the high Session volume 1,871,293 shares, $51,516,696 Relative volume 5.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
73	PVH	-22.22%	2024-04-02 against the close of 2024-04-01 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	PVH Corp. Reports 2023 Fourth Quarter Revenue and Earnings Above Guidance and Provides 2024 Outlook 04/01/2024 16:15 ET after hours	Day +1 -24.50% 2024-04-03 Day +5 -20.90% 2024-04-09 Best recovery within 5 -20.90% 2024-04-09 5.9% of the drop was recovered five sessions later. Month end -22.14% on 2024-04-30
Close before and after $139.73 to $108.68 split-adjusted Session open, high, low $111.50, $113.32, $105.39 Opening gap -20.20% Close inside the session range 0.41 of the range, where 1.00 is the high Session volume 6,741,796 shares, $732,698,389 Relative volume 8.6x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
74	LICY	-22.15%	2024-04-12 against the close of 2024-04-11 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Li-Cycle to Host Annual General and Special Meeting of Shareholders on Thursday, May 23, 2024 at 8:30 a.m. (ET) 04/12/2024 06:15 ET premarket	Day +1 -20.33% 2024-04-15 Day +5 -39.34% 2024-04-19 Best recovery within 5 -18.83% 2024-04-16 Five sessions later the drop was 77.6% bigger, at -39.34%. Month end -40.45% on 2024-04-30
Close before and after $8.80 to $6.85 as traded Session open, high, low $8.48, $8.56, $6.80 Opening gap -3.64% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 1,018,282 shares, $6,975,639 Relative volume 0.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
75	LCFY under $25M today	-22.10%	2024-04-03 against the close of 2024-04-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Locafy Reports Fiscal First Half 2024 Results 04/02/2024 16:10 ET after hours	Day +1 -26.31% 2024-04-04 Day +5 -21.68% 2024-04-10 Best recovery within 5 -11.58% 2024-04-08 1.9% of the drop was recovered five sessions later. Month end -25.54% on 2024-04-30
Close before and after $4.75 to $3.70 split-adjusted Session open, high, low $4.25, $4.42, $3.65 Opening gap -10.53% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 12,814 shares, $47,413 Relative volume 4.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
76	SINT under $25M today More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards	-21.62%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Offering / Dilution	SINTX Technologies Announces Proposed Public Offering of Common Stock 03/29/2024 16:00 ET after hours	Day +1 -17.37% 2024-04-02 Day +5 -49.90% 2024-04-08 Best recovery within 5 -17.37% 2024-04-02 Five sessions later the drop was 130.8% bigger, at -49.90%. Month end -8.28% on 2024-04-30
Close before and after $9.90 to $7.76 split-adjusted Session open, high, low $8.60, $8.74, $7.64 Opening gap -13.13% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 92,882 shares, $720,764 Relative volume 23.6x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
77	OMH under $25M today	-21.36%	2024-04-18 against the close of 2024-04-17 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Ohmyhome Reports 2023 Full-Year Results 04/18/2024 08:30 ET premarket	Day +1 -36.12% 2024-04-19 Day +5 -25.95% 2024-04-25 Best recovery within 5 -25.95% 2024-04-25 Five sessions later the drop was 21.5% bigger, at -25.95%. Month end -28.29% on 2024-04-30
Close before and after $7.67 to $6.03 split-adjusted Session open, high, low $8.00, $8.00, $6.01 Opening gap +4.30% Close inside the session range 0.01 of the range, where 1.00 is the high Session volume 91,378 shares, $551,192 Relative volume 6.9x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
78	SAIA	-21.03%	2024-04-26 against the close of 2024-04-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Saia Reports First Quarter Results 04/26/2024 07:30 ET premarket	Day +1 -23.37% 2024-04-29 Day +5 -26.32% 2024-05-03 Best recovery within 5 -23.37% 2024-04-29 Five sessions later the drop was 25.2% bigger, at -26.32%. Month end -26.92% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $543.02 to $428.81 split-adjusted Session open, high, low $452.09, $479.83, $425.16 Opening gap -16.75% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 2,210,639 shares, $947,944,110 Relative volume 9.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
79	SKIL More than one ranked move this month 2+ ranked moves	-20.93%	2024-04-25 against the close of 2024-04-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Skillsoft Named a "Leader" in Enterprise Learning by Three Industry Analyst Firms 04/25/2024 08:00 ET premarket	Day +1 -15.70% 2024-04-26 Day +5 -16.51% 2024-05-02 Best recovery within 5 -13.14% 2024-05-01 21.1% of the drop was recovered five sessions later. Month end -16.40% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $8.60 to $6.80 split-adjusted Session open, high, low $8.25, $8.49, $6.63 Opening gap -4.07% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 126,855 shares, $862,614 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
80	CADL Also on the opposite board this month on both boards	-20.84%	2024-04-09 against the close of 2024-04-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors 04/09/2024 08:00 ET premarket	Day +1 -20.68% 2024-04-10 Day +5 -8.40% 2024-04-16 Best recovery within 5 +13.22% 2024-04-11 59.7% of the drop was recovered five sessions later. Month end +9.64% on 2024-04-30
Close before and after $6.43 to $5.09 split-adjusted Session open, high, low $6.25, $6.52, $4.88 Opening gap -2.80% Close inside the session range 0.13 of the range, where 1.00 is the high Session volume 3,760,535 shares, $19,141,123 Relative volume 98.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
81	SMXT under $25M today	-20.84%	2024-04-17 against the close of 2024-04-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	SolarMax Technology, Inc. Reports Fiscal Year 2023 Financial Results 04/16/2024 19:35 ET after hours	Day +1 -37.89% 2024-04-18 Day +5 -33.94% 2024-04-24 Best recovery within 5 -24.63% 2024-04-23 Five sessions later the drop was 62.9% bigger, at -33.94%. Month end -19.28% on 2024-04-30
Close before and after $145.68 to $115.32 split-adjusted Session open, high, low $158.88, $158.88, $98.62 Opening gap +9.06% Close inside the session range 0.28 of the range, where 1.00 is the high Session volume 18,789 shares, $2,166,747 Relative volume 1.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
82	TLRY	-20.66%	2024-04-09 against the close of 2024-04-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results 04/09/2024 07:00 ET premarket	Day +1 -22.01% 2024-04-10 Day +5 -29.34% 2024-04-16 Best recovery within 5 -22.01% 2024-04-10 Five sessions later the drop was 42.0% bigger, at -29.34%. Month end -4.63% on 2024-04-30
Close before and after $25.90 to $20.55 split-adjusted Session open, high, low $21.20, $22.50, $20.00 Opening gap -18.15% Close inside the session range 0.22 of the range, where 1.00 is the high Session volume 8,032,989 shares, $165,077,924 Relative volume 2.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
83	EFSH under $25M today	-20.60%	2024-04-17 against the close of 2024-04-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	1847 Reports 59.2% Increase in Revenue to $15.1 Million for the Fourth Quarter of 2023 04/17/2024 08:30 ET premarket	Day +1 -25.75% 2024-04-18 Day +5 +21.89% 2024-04-24 Best recovery within 5 +21.89% 2024-04-24 It recovered the whole drop and closed 21.89% above the pre-news price. Month end +5.15% on 2024-04-30
Close before and after $227.18 to $180.38 as traded Session open, high, low $240.42, $240.42, $174.53 Opening gap +5.83% Close inside the session range 0.09 of the range, where 1.00 is the high Session volume 2,335 shares, $421,176 Relative volume 1.1x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
84	TMQ	-20.44%	2024-04-17 against the close of 2024-04-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	Trilogy Metals Provides Update on the Ambler Access Project 04/17/2024 06:30 ET premarket	Day +1 -25.85% 2024-04-18 Day +5 -19.29% 2024-04-24 Best recovery within 5 -16.54% 2024-04-23 5.6% of the drop was recovered five sessions later. Month end -20.02% on 2024-04-30
Close before and after $0.5029 to $0.4001 split-adjusted Session open, high, low $0.2710, $0.4001, $0.2501 Opening gap -46.11% Close inside the session range 1.00 of the range, where 1.00 is the high Session volume 4,079,600 shares, $1,632,248 Relative volume 28.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
85	KA under $25M today	-20.37%	2024-04-09 against the close of 2024-04-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial 04/08/2024 16:01 ET after hours	Day +1 -31.48% 2024-04-10 Day +5 -11.17% 2024-04-16 Best recovery within 5 -11.17% 2024-04-16 45.2% of the drop was recovered five sessions later. Month end +4.52% on 2024-04-30
Close before and after $0.5400 to $0.4300 as traded Session open, high, low $0.4711, $0.4880, $0.4120 Opening gap -12.76% Close inside the session range 0.24 of the range, where 1.00 is the high Session volume 1,235,417 shares, $531,229 Relative volume 12.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
86	BCLI under $25M today Also on the opposite board this month on both boards	-20.21%	2024-04-09 against the close of 2024-04-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS 04/09/2024 06:00 ET premarket	Day +1 -17.60% 2024-04-10 Day +5 -27.79% 2024-04-16 Best recovery within 5 -17.60% 2024-04-10 Five sessions later the drop was 37.5% bigger, at -27.79%. Month end -48.29% on 2024-04-30
Close before and after $10.95 to $8.74 split-adjusted Session open, high, low $10.95, $11.10, $8.55 Opening gap 0.00% Close inside the session range 0.07 of the range, where 1.00 is the high Session volume 314,770 shares, $2,750,303 Relative volume 7.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
87	WLDS under $25M today	-20.09%	2024-04-25 against the close of 2024-04-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Uplisting / Compliance	Wearable Devices Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement 04/24/2024 16:15 ET after hours	Day +1 -20.52% 2024-04-26 Day +5 -26.61% 2024-05-02 Best recovery within 5 -19.22% 2024-04-30 Five sessions later the drop was 32.5% bigger, at -26.61%. Month end -19.22% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $333.36 to $266.40 split-adjusted Session open, high, low $331.20, $331.20, $264.60 Opening gap -0.65% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 656 shares, $174,758 Relative volume 2.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
88	BMRA under $25M today	-19.95%	2024-04-29 against the close of 2024-04-26 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement 04/29/2024 08:19 ET premarket	Day +1 -10.41% 2024-04-30 Day +5 -11.58% 2024-05-06 Best recovery within 5 -5.28% 2024-05-01 42.0% of the drop was recovered five sessions later. Month end -10.41% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $5.32 to $4.26 split-adjusted Session open, high, low $5.84, $6.31, $4.00 Opening gap +9.77% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 874,768 shares, $3,726,512 Relative volume 115.4x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
89	CVKD under $25M today	-19.86%	2024-04-09 against the close of 2024-04-08 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	FDA & Regulatory	Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts 04/09/2024 09:00 ET premarket	Day +1 -13.27% 2024-04-10 Day +5 -23.55% 2024-04-16 Best recovery within 5 -13.27% 2024-04-10 Five sessions later the drop was 18.6% bigger, at -23.55%. Month end -13.73% on 2024-04-30
Close before and after $7.65 to $6.13 split-adjusted Session open, high, low $8.59, $8.69, $5.67 Opening gap +12.27% Close inside the session range 0.15 of the range, where 1.00 is the high Session volume 406,336 shares, $2,491,043 Relative volume 115.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
90	CAUD under $25M today Also on the opposite board this month on both boards	-19.59%	2024-04-08 against the close of 2024-04-05 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	M&A / Acquisition	Collective Audience to Acquire Marketing-as-a-Service Provider, DSL Digital, Enabling Launch of AI-Powered AudienceServices(TM) 04/08/2024 08:31 ET premarket	Day +1 -21.05% 2024-04-09 Day +5 -31.15% 2024-04-15 Best recovery within 5 -21.05% 2024-04-09 Five sessions later the drop was 59.0% bigger, at -31.15%. Month end -0.93% on 2024-04-30
Close before and after $0.6964 to $0.5600 split-adjusted Session open, high, low $0.7700, $0.8044, $0.5300 Opening gap +10.57% Close inside the session range 0.11 of the range, where 1.00 is the high Session volume 6,934,036 shares, $3,883,060 Relative volume 57.1x the median of the 20 sessions before the pre-news close Baseline gap 3 calendar days from the pre-news close to the measured session
91	SAGE	-19.58%	2024-04-17 against the close of 2024-04-16 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Sage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s Disease 04/17/2024 06:30 ET premarket	Day +1 -16.60% 2024-04-18 Day +5 -10.43% 2024-04-24 Best recovery within 5 -10.43% 2024-04-24 46.7% of the drop was recovered five sessions later. Month end -10.81% on 2024-04-30
Close before and after $15.63 to $12.57 as traded Session open, high, low $12.96, $13.42, $10.92 Opening gap -17.08% Close inside the session range 0.66 of the range, where 1.00 is the high Session volume 4,315,890 shares, $54,250,737 Relative volume 5.5x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
92	LW	-19.37%	2024-04-04 against the close of 2024-04-03 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Lamb Weston Reports Fiscal Third Quarter 2024 Results; Updates Fiscal Year 2024 Outlook 04/04/2024 08:30 ET premarket	Day +1 -21.10% 2024-04-05 Day +5 -19.54% 2024-04-11 Best recovery within 5 -19.54% 2024-04-11 Five sessions later the drop was 0.9% bigger, at -19.54%. Month end -17.58% on 2024-04-30
Close before and after $101.12 to $81.53 split-adjusted Session open, high, low $88.53, $89.48, $80.02 Opening gap -12.45% Close inside the session range 0.16 of the range, where 1.00 is the high Session volume 23,227,128 shares, $1,893,707,746 Relative volume 16.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
93	HTZ	-19.31%	2024-04-25 against the close of 2024-04-24 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	HERTZ REPORTS FIRST QUARTER 2024 RESULTS 04/25/2024 07:30 ET premarket	Day +1 -23.79% 2024-04-26 Day +5 -13.79% 2024-05-02 Best recovery within 5 -13.79% 2024-05-02 28.6% of the drop was recovered five sessions later. Month end -21.55% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $5.80 to $4.68 split-adjusted Session open, high, low $5.17, $5.30, $4.35 Opening gap -10.86% Close inside the session range 0.35 of the range, where 1.00 is the high Session volume 26,629,270 shares, $124,624,984 Relative volume 5.4x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
94	RZLT	-19.21%	2024-04-23 against the close of 2024-04-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Clinical Trial Results	Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting 04/23/2024 08:00 ET premarket	Day +1 -18.36% 2024-04-24 Day +5 -24.29% 2024-04-30 Best recovery within 5 -18.36% 2024-04-24 Five sessions later the drop was 26.4% bigger, at -24.29%. Month end -24.29% on 2024-04-30
Close before and after $3.54 to $2.86 split-adjusted Session open, high, low $3.65, $3.68, $2.67 Opening gap +3.11% Close inside the session range 0.19 of the range, where 1.00 is the high Session volume 940,007 shares, $2,688,420 Relative volume 3.7x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
95	AKTX under $25M today	-19.03%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights 04/01/2024 06:30 ET premarket	Day +1 -19.03% 2024-04-02 Day +5 -24.93% 2024-04-08 Best recovery within 5 -16.89% 2024-04-03 Five sessions later the drop was 31.0% bigger, at -24.93%. Month end -17.43% on 2024-04-30
Close before and after $74.60 to $60.40 split-adjusted Session open, high, low $74.00, $74.00, $60.00 Opening gap -0.80% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 2,795 shares, $168,818 Relative volume 13.0x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session
96	OIS	-18.98%	2024-04-26 against the close of 2024-04-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Oil States Announces First Quarter 2024 Results 04/26/2024 07:00 ET premarket	Day +1 -23.87% 2024-04-29 Day +5 -18.80% 2024-05-03 Best recovery within 5 -18.80% 2024-05-03 0.9% of the drop was recovered five sessions later. Month end -25.00% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $5.32 to $4.31 split-adjusted Session open, high, low $4.98, $5.16, $4.22 Opening gap -6.39% Close inside the session range 0.10 of the range, where 1.00 is the high Session volume 6,593,460 shares, $28,417,813 Relative volume 6.3x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
97	JBLU	-18.77%	2024-04-23 against the close of 2024-04-22 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	JetBlue Announces First Quarter 2024 Results 04/23/2024 06:30 ET premarket	Day +1 -21.30% 2024-04-24 Day +5 -24.37% 2024-04-30 Best recovery within 5 -21.30% 2024-04-24 Five sessions later the drop was 29.8% bigger, at -24.37%. Month end -24.37% on 2024-04-30
Close before and after $7.51 to $6.10 split-adjusted Session open, high, low $6.11, $6.74, $6.00 Opening gap -18.64% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 37,018,575 shares, $225,813,308 Relative volume 3.8x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
98	INVE	-18.70%	2024-04-03 against the close of 2024-04-02 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Contract / Partnership	Identiv Announces Asset Purchase Agreement with Security Solutions Provider Vitaprotech for $145 Million 04/03/2024 06:40 ET premarket	Day +1 -29.23% 2024-04-04 Day +5 -39.05% 2024-04-10 Best recovery within 5 -29.23% 2024-04-04 Five sessions later the drop was 108.8% bigger, at -39.05%. Month end -40.36% on 2024-04-30
Close before and after $8.45 to $6.87 split-adjusted Session open, high, low $8.05, $8.21, $6.66 Opening gap -4.73% Close inside the session range 0.14 of the range, where 1.00 is the high Session volume 403,035 shares, $2,768,850 Relative volume 5.0x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
99	NKGN under $25M today Also on the opposite board this month on both boards	-18.69%	2024-04-26 against the close of 2024-04-25 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Other Announcement	NKGen Biotech Presents Updated NK Cell Therapy Data for Neurodegenerative Disease at the 12th Annual Alzheimer’s & Parkinson’s Drug Development Summit 04/25/2024 16:05 ET after hours	Day +1 -17.17% 2024-04-29 Day +5 -27.78% 2024-05-03 Best recovery within 5 -17.17% 2024-04-29 Five sessions later the drop was 48.6% bigger, at -27.78%. Month end -23.74% on 2024-04-30 This month ended before the fifth session after the move.
Close before and after $1.98 to $1.61 split-adjusted Session open, high, low $1.90, $1.95, $1.60 Opening gap -4.04% Close inside the session range 0.03 of the range, where 1.00 is the high Session volume 546,549 shares, $879,944 Relative volume 2.2x the median of the 20 sessions before the pre-news close Baseline gap 1 calendar day from the pre-news close to the measured session
100	GNLX	-18.51%	2024-04-01 against the close of 2024-03-28 session reconstructed Session detail Market cap is not shown on months older than a year, because only today's figure exists.	Earnings	Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update 04/01/2024 07:00 ET premarket	Day +1 -18.35% 2024-04-02 Day +5 -27.37% 2024-04-08 Best recovery within 5 -18.35% 2024-04-02 Five sessions later the drop was 47.9% bigger, at -27.37%. Month end -51.63% on 2024-04-30
Close before and after $6.43 to $5.24 split-adjusted Session open, high, low $6.50, $6.50, $5.07 Opening gap +1.09% Close inside the session range 0.12 of the range, where 1.00 is the high Session volume 161,939 shares, $848,560 Relative volume 2.2x the median of the 20 sessions before the pre-news close Baseline gap 4 calendar days from the pre-news close to the measured session

NYSE and Nasdaq companies with a market capitalization of $5M or more, measured today, including the $5M to $25M band. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 288 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Exclude the $5M to $25M band

2 candidate events for this board could not be anchored to a trading session and are not listed.

6 events were left out of this board because the measured session set no price of its own, trading either nothing at all or barely moving on an ordinary day's volume, so the figure it would be ranked on is a price carried onto the tape rather than a close.

1 event was left out of this board because the measured session changed hands for less than $25,000 in total, so the percentage prices a handful of shares rather than a move anyone could have taken.

2 events were left out of this board because the ticker had not traded for more than 10 days before the measured session, so no comparable prior close exists.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In April 2024, the median decliner was 8.8% deeper below its pre-news close five sessions later; the largest catalyst group was Earnings, 31 of the 100 events, at a median of -23.6%.

Close-to-close change on the measured trading session, against the previous close.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst	Events	Share of board	Median move close to close	Median at day +5	Still below the pre-news close at day +5
Earnings	31	31.0%	-23.6%	-26.8%	96.8% of 31
Other Announcement	24	24.0%	-27.3%	-32.1%	87.5% of 24
Offering / Dilution	15	15.0%	-33.3%	-32.7% of 14	92.9% of 14
Clinical Trial Results	13	13.0%	-27.3%	-29.2%	100.0% of 13
Uplisting / Compliance	5	5.0%	Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

5 other catalyst types, 12 events: Contract / Partnership, FDA & Regulatory, M&A / Acquisition, Leadership Change, Reverse Merger / Shell.

How much of the drop held

Horizon	Still below the pre-news close close to close	Median change since the measured close as a share of the drop
Day +1	99.0% of 100	4.6% deeper below baseline, of 100
Day +5	92.9% of 99	8.8% deeper below baseline, of 99
Month end	90.4% of 94	10.4% deeper below baseline, of 94
Month end falls before day +5 for 14 of these 94 events, so this row is not a later horizon than the one above it. 94 of the 100 events have a month-end close later than the measured session; 4 have it on the measured session itself, and 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside April 2024

Two or more ranked moves this month, each on a different trading day.

Symbol	Measured sessions	Largest drop
SINT	2Offering / Dilution	-43.77%
SKIL	2Earnings, Other Announcement	-40.76%
WISA	2Other Announcement	-36.32%
MTBL	2Uplisting / Compliance, Other Announcement	-33.33%
NRXP	2Offering / Dilution, Clinical Trial Results	-27.75%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

Symbol	Months	Largest drop
SINTthis month too	2024-03, 2024-01	-45.95%
EVA	2024-03, 2024-01	-35.38%
NRXPthis month too	2024-03, 2024-02	-34.32%
SIDU	2024-03, 2024-01	-44.25%
SLS	2024-03, 2024-01	-35.77%
HSCS	2024-03, 2024-01	-27.41%
NYCB	2024-03, 2024-01	-37.67%
ELTK	2024-03, 2024-02	-26.95%
CURO	2024-03, 2024-02	-41.04%
SQNS	2024-03, 2024-02	-64.86%
AEHR	2024-03, 2024-01	-22.44%
DMAQ	2024-02, 2024-01	-100.00%
TCS	2024-02, 2024-01	-39.41%
SMX	2024-02, 2024-01	-37.61%
DTSS	2024-02, 2024-01	-28.64%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

Volume against normal

Industry

33 other industries, 36 events

Industry not known: 22.0%

1 event on this board carries the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against March 2024

100 events in the comparable window.

March 2024 median -28.1%, selected from the 8,829 events in that month's eligible pool

April 2024 median -27.5%, 0.6 points shallower than March 2024. April 2024's median is taken over the 100 ranked rows, selected from the 10,268 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.